Home Aminos 2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-

2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-

CAS No.:
4936-47-4
Catalog Number:
AG00I8UI
Molecular Formula:
C10H11N3O5S
Molecular Weight:
285.2764
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%(HPLC)
In Stock USA
United States
$155
- +
5g
98%(HPLC)
In Stock USA
United States
$433
- +
Product Description
Catalog Number:
AG00I8UI
Chemical Name:
2-Oxazolidinone,5-[(methylthio)methyl]-3-[[(5-nitro-2-furanyl)methylene]amino]-
CAS Number:
4936-47-4
Molecular Formula:
C10H11N3O5S
Molecular Weight:
285.2764
MDL Number:
MFCD00057257
IUPAC Name:
5-(methylsulfanylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
InChI:
InChI=1S/C10H11N3O5S/c1-19-6-8-5-12(10(14)18-8)11-4-7-2-3-9(17-7)13(15)16/h2-4,8H,5-6H2,1H3/b11-4+
InChI Key:
SRQKTCXJCCHINN-NYYWCZLTSA-N
SMILES:
[O-][N+](=O)c1ccc(o1)/C=N/N1CC(OC1=O)CSC
EC Number:
225-576-2
Properties
Complexity:
386  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
285.042g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
285.274g/mol
Monoisotopic Mass:
285.042g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
126A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  
Literature
Title Journal
Bacterial vaginosis, Atopobium vaginae and nifuratel. Current clinical pharmacology 20120201
[Rifaksimin in complex treatment of Helicobacter pylori infection in children (a pilot study)]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20090101
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry 20081113
Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. Helicobacter 20070401
An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies. European journal of drug metabolism and pharmacokinetics 20070101
Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone. Alimentary pharmacology & therapeutics 20051101
['Mixed' and 'miscellaneous' vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel]. Ceska gynekologie 20050501
Determination of nifuratel in human plasma by HPLC and study on its pharmacokinetics. Journal of chromatographic science 20050401
[The Melkersson-Rosenthal syndrome as a problem of complex treatment]. Wiadomosci lekarskie (Warsaw, Poland : 1960) 20040101
Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections. Arzneimittel-Forschung 20030101
Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. Journal of the National Cancer Institute 19751101
Properties